Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT

M. M. M. Chowdhury, C. Pao, C. Pearson, A. Shah, E. Reus, A. Devlin-Jolliffe, J. Lawton, S. McKenzie, P. Habibi (London, United Kingdom; Adelaide, Australia)

Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Session: Diagnosis and treatment of viral respiratory infections in early childhood
Session type: Thematic Poster Session
Number: 3998
Disease area: Paediatric lung diseases, Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. M. M. Chowdhury, C. Pao, C. Pearson, A. Shah, E. Reus, A. Devlin-Jolliffe, J. Lawton, S. McKenzie, P. Habibi (London, United Kingdom; Adelaide, Australia). Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT. Eur Respir J 2009; 34: Suppl. 53, 3998

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis.
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018


Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment
Year: 2018




A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Recombinant human deoxyribonuclease (rhDNase) for the treatment of acute asthma in children: a multicentre randomised double-blind clinical trial
Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up
Year: 2007


The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial
Source: Eur Respir J 2006; 28: Suppl. 50, 758s
Year: 2006

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Source: Eur Respir J, 51 (1) 1702053; 10.1183/13993003.02053-2017
Year: 2018



RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Source: Eur Respir J, 51 (1) 1702052; 10.1183/13993003.02052-2017
Year: 2018



Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Risankizumab in severe asthma: A Phase IIa, placebo-controlled study
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020



A pilot randomised controlled study of oxygen delivery via vapotherm in infants with moderately severe acute bronchiolitis
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017



Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010